Clinical trials: Trauma-related Stressor
Post-traumatic Stress Disorder, Post Traumatic Stress Disorder
A Clinical Trial of PRAX-114 in Participants With Post-Traumatic Stress Disorder
This trial is comprised of a 4-week randomized, double-blind, placebo-controlled treatment period followed by an optional 8-week open-label extension (OLE) period.
- Conditions
- Post-traumatic Stress Disorder, Post Traumatic Stress Disorder, Stress Disorder, Stress Disorders, Post-Traumatic
- Trial name
- NCT05260541
- Testing
- 60 mg PRAX-114 or 40 mg PRAX-114, 40 mg PRAX-114
- Where
- 17 sites in United States
- Volunteers
- 11 people
- Sponsor
- Praxis Precision Medicines